OTTAWA, Feb. 5, 2018 /CNW/ - The Canadian Medical Association (CMA) is advocating for regulations that protect Canadiansfrom misleading claims on health products containing cannabis, and is urging the government to adopt a public health approach. The CMA's recommendations were presented to the federal government as part of its consultation on the proposed approach to
The CMA is concerned that — despite being regulated by Health Canada — non-prescription drugs, natural health products, cosmetics and medical devices undergo different levels of scrutiny than prescription drugs. Many consumers may not be aware of this discrepancy. In addition, health claims made on these products are often not substantiated, as the industry isn't required to provide scientific evidence to back them up.
"Ensuring that health products are safe and effective must be a key component of any regulations on cannabis. We believe rigorous scientific evidence is needed to support claims of health benefits, and to identify potential risks and adverse reactions," says Dr. Laurent Marcoux, president of the CMA.
For the packaging and labelling of cannabis, the CMA recommends that government officials and health professionals — not cannabis producers or distributors — design the packaging, to emphasize the health risks associated with consumption. Like tobacco and cigarettes, cannabis packaging and labeling provide an opportunity to raise awareness of the health, social and economic harms of use, especially in youth.
In addition, the association maintains its position that only one system and one set of regulations should be in place for both medical and recreational cannabis, to avoid redundancy and disparity in regulations.
The CMA has consistently advocated for a public health approach in the legalization and regulation of cannabis. This includes public health promotion, harm reduction strategies, prevention of dependency and access to treatment.
The Canadian Medical Association unites 85,000 physicians on national health and medical matters. Formed in Quebec City in 1867, the CMA's rich history of advocacy led to some of Canada's most important health policy changes. As we look to the future, the CMA will focus on advocating for a healthy population and a vibrant profession.
SOURCE Canadian Medical Association
Subscribe to our Free Newsletters!
Osteolysis refers to breaking down of bone tissue. Bone loss occurs due to resorption of bone by ...
Patisiran injection, recently approved by FDA to treat polyneuropathy, a disease that causes ...
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...View All